75N94025D00003↗
Duke University received this contract vehicle from National Institutes of Health Nichd, National Institutes of Health: $0 obligated so far for health r&d services; health care services; basic research. It runs to 2033-06-03.
Key facts · data as of Oct 26, 2026
- Recipient
- Duke University
- Awarding agency
- National Institutes of Health (Department of Health and Human Services)
- Contracting office
- National Institutes of Health Nichd (75N940)
- Obligated to date
- $0
- Potential value
- $149.00M
- Ends
- 2033-06-03
Source: USAspending.gov prime award records (obligations: money committed, not outlays), data as of Oct 26, 2026.
Cite this page: SpendQuery, Award 75N94025D00003, data as of Oct 26, 2026, https://spendquery.com/award?id=CONT_IDV_75N94025D00003_7529
Duke University: all federal awards · Department of Health and Human Services: spending · National Institutes of Health Nichd: what it buys
NICHD: R&D: BEST PHARMACEUTICALS FOR CHILDREN ACT (BPCA) PEDIATRIC TRIALS NETWORK (PTN): NON-SEVERABLE
What it is
- Product or service
- Health R&D Services; Health Care Services; Basic Research (PSC AN11)
- Industry
- Research and Development in the Physical, Engineering, and Life Sciences (Except Nanotechnology and Biotechnology) (NAICS 541715)
- Contracting office
- National Institutes of Health Nichd (75N940)
- Competition
- Full and open competition · 1 offer received
- Pricing
- Order dependent (set on each order)
- How it was bought
- Contract vehicle (IDV) itself
- Solicitation
- 75N94024R00008
Obligations by fiscal year
SpendQuery holds FY2023 on; earlier years are on USAspending.gov.
Subcontractors: where the money went next
1 subaward totaling $150.0K (14999900.0% of what was obligated), as Duke University reported them. Primes report subawards of $30,000 or more; smaller ones and unreported ones aren't here.
| Subcontractor | Amount | Subawards | Where | First | Last |
|---|---|---|---|---|---|
| University of Utah | $150.0K | 1 | UT | 2026-02-25 | 2026-02-25 |
The largest single subawards
| Date | To | Amount | For |
|---|---|---|---|
| 2026-02-25 | University of Utah | $150.0K | DCRI #D2168 PTN 3.0 TO2: DECENTRALIZED CLINICAL TRIALS |
Orders under this vehicle
4 orders worth $23.79M (current value). The largest:
- 75N94026F00002 · $8.30M · ends 2030-09-27
- 75N94026F00001 · $5.70M · ends 2030-06-28
- 75N94025F00002 · $5.00M · ends 2027-09-19
- 75N94025F00001 · $4.79M · ends 2027-06-03
Every action
3 actions since 2025-06-04. Each is a modification or amendment with the money it added or took back.
| Date | Modification | Kind | Amount | What the agency wrote |
|---|---|---|---|---|
| 2026-08-20 | P00002 | Administrative change | $0 | NICHD: R&D: BEST PHARMACEUTICALS FOR CHILDREN ACT (BPCA) PEDIATRIC TRIALS NETWORK (PTN): NON-SEVERABLE |
| 2026-07-16 | P00001 | Administrative change | $0 | EO 14398 NICHD: R&D: BEST PHARMACEUTICALS FOR CHILDREN ACT (BPCA) PEDIATRIC TRIALS NETWORK (PTN): NON-SEVERABLE |
| 2025-06-04 | 0 | $0 | NICHD: R&D: BEST PHARMACEUTICALS FOR CHILDREN ACT (BPCA) PEDIATRIC TRIALS NETWORK (PTN): NON-SEVERABLE |
Source: USAspending.gov prime award transactions and FSRS subaward reports, as loaded by SpendQuery (data as of 2026-10-26). Amounts are obligations (money committed), not outlays. The official record on USAspending.gov ↗